Beitou Health Management Hospital · Taipei · District hospital

High Precision Medical Imaging Health Checkup (A)

Name: High Precision Medical Imaging Health Checkup (A)
Brand: Beitou Health Management Hospital
Price: 180076 TWD
Availability: InStock

US$5,610

NT$180,076 · you pay the hospital in NT$

Book this checkup

Prefer to book it yourself? Call Beitou Health Management Hospital on 0800-015-104 or use its website ↗. It's free; most hospitals take bookings in Chinese.

We book it with the hospital for you, from US$149, paid only after the hospital confirms. We reply by email with available dates, the confirmed price, and whether an English report is available.

Paying from a US account? HSA and FSA notes.

Share on LINE / 分享到 LINE

As published by the hospital · checked 2026-09-20

An executive-tier program with Brain MR angiography, Abdominal MRI / MRCP, Brain MRI, Breast MRI and Pelvic MRI and a 74-test panel, with a doctor's review at the end.

Sedation

Available

Bowel prep

Required

English report

Ask the hospital (we ask for you in Book it for me)

What stands out

Brain MR angiography

Aneurysms and narrowed brain arteries.

Abdominal MRI / MRCP

Liver, pancreas and bile duct tumors and disease.

Brain MRI

Brain tumors, small strokes, aneurysms and early degeneration.

Breast MRI

Breast cancer in high-risk women.

Every test, in English

74 tests listed, 67 of them on our shared test list, so they line up against other hospitals' packages.

Vitals1

Blood Count1

Liver Function9

Kidney & Electrolytes4

Lipids & Cardiometabolic6

Glucose3

Thyroid & Endocrine6

Tumor Markers5

Infection Serology3

Urine & Stool1

Cardiac1

Pulmonary1

Ultrasound6

CT Imaging3

MRI Imaging6

Endoscopy3

Women's Health1

Bone & Body Composition1

Eye1

ENT & Dental2

Neuro & Cognitive1

Consultation2

Show all 74 tests and what each screens for

Test	Screens for
Vitals
Body composition analysis	Body fat, muscle mass and water percentage.
Blood Count
Complete blood count	Anemia, infection and blood cell disorders.
Liver Function
Albumin	Liver function and nutrition status.
Alkaline phosphatase	Liver, bile duct and bone conditions.
ALT (SGPT)	Liver cell damage; the most common liver screening test.
AST (SGOT)	Liver cell damage.
Direct bilirubin	Bile duct obstruction.
Gamma-GT	Bile duct and alcohol-related liver stress.
Globulin and A/G ratio	Immune protein levels.
Lipase	Pancreatic enzyme; more specific than amylase for pancreatitis.
Total bilirubin	Jaundice, liver and bile problems.
Kidney & Electrolytes
Blood urea nitrogen	Kidney function.
Creatinine	Kidney function.
Estimated GFR	Kidney filtering capacity; stages chronic kidney disease.
Uric acid	Gout risk and kidney stone risk.
Lipids & Cardiometabolic
Total cholesterol / HDL ratio	A calculated ratio of total cholesterol to HDL cholesterol used in some cardiovascular risk calculators.
HDL cholesterol	Protective cholesterol level.
High-sensitivity CRP	Inflammation linked to heart disease risk.
LDL cholesterol	The main cholesterol driving heart disease risk.
Total cholesterol	Cardiovascular risk.
Triglycerides	Cardiovascular and pancreatitis risk.
Glucose
Fasting glucose	Diabetes and prediabetes.
Hemoglobin A1c	Average blood sugar over the past three months; diabetes.
Fasting insulin	Insulin resistance.
Thyroid & Endocrine
DHEA-S	Adrenal androgen level.
Female hormone panel (FSH, LH, E2)	Menopause status and hormone balance.
Free T4	Thyroid hormone level.
Testosterone	Male hormone level; low testosterone.
TSH	Thyroid function; the primary thyroid screening test.
Vitamin D (25-OH)	Vitamin D deficiency; bone health.
Tumor Markers
AFP	Liver cancer marker (also used with liver ultrasound in hepatitis B carriers).
CA-125	Ovarian cancer marker.
CA 19-9	Pancreatic and biliary cancer marker.
CEA	Colorectal and other GI cancer marker.
PSA	Prostate cancer marker.
Infection Serology
Hepatitis B surface antibody	Immunity to hepatitis B (from vaccine or past infection).
Hepatitis C antibody	Hepatitis C infection.
Hepatitis B surface antigen	Current hepatitis B infection; very common in Taiwan.
Urine & Stool
Urinalysis	Kidney disease, urinary infection, diabetes.
Cardiac
Resting ECG	Heart rhythm and signs of prior heart damage.
Pulmonary
Lung function test	Asthma, COPD and lung capacity.
Ultrasound
Abdominal ultrasound	Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.
Breast ultrasound	Breast lumps; complements mammography, especially in dense breasts.
Carotid ultrasound	Plaque in the neck arteries; stroke risk.
Liver elastography (FibroScan)	Liver scarring and fat without a biopsy.
Pelvic (gynecologic) ultrasound	Uterus and ovary abnormalities (fibroids, cysts).
Thyroid ultrasound	Thyroid nodules.
CT Imaging
Coronary artery calcium score	Calcified plaque in heart arteries; refines heart attack risk.
Coronary CT angiography	Narrowing of the heart arteries without a catheter.
Low-dose chest CT	Early lung cancer; the USPSTF recommends it yearly for some adults 50 to 80 with a heavy smoking history.
MRI Imaging
Brain MR angiography	Aneurysms and narrowed brain arteries.
Abdominal MRI / MRCP	Liver, pancreas and bile duct tumors and disease.
Brain MRI	Brain tumors, small strokes, aneurysms and early degeneration.
Breast MRI	Breast cancer in high-risk women.
Pelvic MRI	Pelvic organ abnormalities.
Whole spine MRI	Whole spine survey.
Endoscopy
Colonoscopy	Colon polyps and colorectal cancer; polyps can usually be removed during the same exam.
Gastroscopy (upper GI endoscopy)	Stomach and esophagus ulcers, inflammation and cancer.
Nasopharyngoscopy	Nasopharyngeal and throat abnormalities.
Women's Health
HPV DNA test	High-risk HPV strains that cause cervical cancer.
Bone & Body Composition
Bone density (DXA)	Osteoporosis and fracture risk.
Eye
General eye exam	Overall eye examination.
ENT & Dental
Hearing test	Hearing loss.
ENT examination	Ear, nose and throat abnormalities.
Neuro & Cognitive
Autonomic nervous system (HRV) test	Stress and autonomic balance.
Consultation
Physician physical examination	A doctor's hands-on examination and history taking.
Physician consultation and report review	A doctor explains your results and what to do next.

Vitals

Body composition analysis

Body fat, muscle mass and water percentage.

Blood Count

Complete blood count

Anemia, infection and blood cell disorders.

Liver Function

Albumin

Liver function and nutrition status.

Alkaline phosphatase

Liver, bile duct and bone conditions.

ALT (SGPT)

Liver cell damage; the most common liver screening test.

AST (SGOT)

Liver cell damage.

Direct bilirubin

Bile duct obstruction.

Gamma-GT

Bile duct and alcohol-related liver stress.

Globulin and A/G ratio

Immune protein levels.

Lipase

Pancreatic enzyme; more specific than amylase for pancreatitis.

Total bilirubin

Jaundice, liver and bile problems.

Kidney & Electrolytes

Blood urea nitrogen

Kidney function.

Creatinine

Kidney function.

Estimated GFR

Kidney filtering capacity; stages chronic kidney disease.

Uric acid

Gout risk and kidney stone risk.

Lipids & Cardiometabolic

Total cholesterol / HDL ratio

A calculated ratio of total cholesterol to HDL cholesterol used in some cardiovascular risk calculators.

HDL cholesterol

Protective cholesterol level.

High-sensitivity CRP

Inflammation linked to heart disease risk.

LDL cholesterol

The main cholesterol driving heart disease risk.

Total cholesterol

Cardiovascular risk.

Triglycerides

Cardiovascular and pancreatitis risk.

Glucose

Fasting glucose

Diabetes and prediabetes.

Hemoglobin A1c

Average blood sugar over the past three months; diabetes.

Fasting insulin

Insulin resistance.

Thyroid & Endocrine

DHEA-S

Adrenal androgen level.

Female hormone panel (FSH, LH, E2)

Menopause status and hormone balance.

Free T4

Thyroid hormone level.

Testosterone

Male hormone level; low testosterone.

TSH

Thyroid function; the primary thyroid screening test.

Vitamin D (25-OH)

Vitamin D deficiency; bone health.

Tumor Markers

AFP

Liver cancer marker (also used with liver ultrasound in hepatitis B carriers).

CA-125

Ovarian cancer marker.

CA 19-9

Pancreatic and biliary cancer marker.

CEA

Colorectal and other GI cancer marker.

PSA

Prostate cancer marker.

Infection Serology

Hepatitis B surface antibody

Immunity to hepatitis B (from vaccine or past infection).

Hepatitis C antibody

Hepatitis C infection.

Hepatitis B surface antigen

Current hepatitis B infection; very common in Taiwan.

Urine & Stool

Urinalysis

Kidney disease, urinary infection, diabetes.

Cardiac

Resting ECG

Heart rhythm and signs of prior heart damage.

Pulmonary

Lung function test

Asthma, COPD and lung capacity.

Ultrasound

Abdominal ultrasound

Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.

Breast ultrasound

Breast lumps; complements mammography, especially in dense breasts.

Carotid ultrasound

Plaque in the neck arteries; stroke risk.

Liver elastography (FibroScan)

Liver scarring and fat without a biopsy.

Pelvic (gynecologic) ultrasound

Uterus and ovary abnormalities (fibroids, cysts).

Thyroid ultrasound

Thyroid nodules.

CT Imaging

Coronary artery calcium score

Calcified plaque in heart arteries; refines heart attack risk.

Coronary CT angiography

Narrowing of the heart arteries without a catheter.

Low-dose chest CT

Early lung cancer; the USPSTF recommends it yearly for some adults 50 to 80 with a heavy smoking history.

MRI Imaging

Brain MR angiography

Aneurysms and narrowed brain arteries.

Abdominal MRI / MRCP

Liver, pancreas and bile duct tumors and disease.

Brain MRI

Brain tumors, small strokes, aneurysms and early degeneration.

Breast MRI

Breast cancer in high-risk women.

Pelvic MRI

Pelvic organ abnormalities.

Whole spine MRI

Whole spine survey.

Endoscopy

Colonoscopy

Colon polyps and colorectal cancer; polyps can usually be removed during the same exam.

Gastroscopy (upper GI endoscopy)

Stomach and esophagus ulcers, inflammation and cancer.

Nasopharyngoscopy

Nasopharyngeal and throat abnormalities.

Women's Health

HPV DNA test

High-risk HPV strains that cause cervical cancer.

Bone & Body Composition

Bone density (DXA)

Osteoporosis and fracture risk.

Eye

General eye exam

Overall eye examination.

ENT & Dental

Hearing test

Hearing loss.

ENT examination

Ear, nose and throat abnormalities.

Neuro & Cognitive

Autonomic nervous system (HRV) test

Stress and autonomic balance.

Consultation

Physician physical examination

A doctor's hands-on examination and history taking.

Physician consultation and report review

A doctor explains your results and what to do next.

Also listed: Beta-hCG, H. pylori test (gastroscopy), Liquid-based Pap smear, Low-residue meal replacement for colonoscopy, Peripheral arterial stiffness test, SHBG (sex hormone-binding globulin), Small dense LDL (sdLDL). And 2 further items the hospital lists only in Chinese.

Before you book

SedationAvailable

Bowel prepRequired

If something is foundAsk the hospital how any findings are explained, on the day or at a follow-up appointment; in Book it for me we ask for you and tell you before you book. Your own doctor decides what to do next; we do not arrange treatment.

Results and imagingAsk the hospital how long results take and how imaging is delivered; in Book it for me we ask for you and tell you before you book.

Beitou Health Management Hospital

District hospital

Taipei · Beitou

On the OCAC i僑卡 partner list. Card holders can ask the center about a discount.

12 packages listed

About this hospital

What the center says

From the center's own pages, in English. Each statement links to its source.

Booking and payment

For general check-in, the center accepts any one of: ID card, National Health Insurance card, driver's license, passport, or resident certificate.
Source ↗ · checked 2026-09-20

Before and on the day

For the standard health checkup, patients must begin fasting, including water and chewing gum, from midnight the night before the checkup.
Source ↗ · checked 2026-09-20
Patients on medication for chronic conditions such as hypertension, cardiovascular disease or diabetes are asked to stop taking them the morning of the checkup (except an asthma inhaler) and to bring the medication to take after all exams are done.
Source ↗ · checked 2026-09-20
Patients who are pregnant or may be pregnant are asked to tell the technicians directly so they can be excluded from X-ray exams and Pap tests.
Source ↗ · checked 2026-09-20
Patients scheduled for an intraocular pressure test are asked not to wear contact lenses on the day of the exam.
Source ↗ · checked 2026-09-20
Patients are asked to bring a stool sample with them to the checkup.
Source ↗ · checked 2026-09-20

Ask your own doctor before changing any medicine.

Results

A specialist physician explains the checkup results one-on-one on the same day.
Source ↗ · checked 2026-09-20
Checkup reports are delivered electronically through the app and by email; a paper copy costs extra.
Source ↗ · checked 2026-09-20

US price context

Bought one by one at US cash-pay marketplaces, the tests we could price list at about US$13,380–17,807 for a woman (64 of 66 tests) and US$11,830–16,139 for a man (59 of 61 tests) (MDsave, Quest and others; checked 2026-10-11).

Executive physicals at top US hospitals ran US$1,700–10,000 (JAMA, 2019).

How we priced it

A panel counts once however many of its tests the package lists. A test for one sex only is counted only for that sex. Tests we could not price are left out, so this is not what a US checkup would cost. Prices marked "rough" come from a single reseller or are extrapolated from a similar test.

Abdominal ultrasound: US$150–375, MDsave, ultrasound one body area
AFP: US$50, shayahealth.com (reseller), rough
Hepatitis C antibody: US$62, Quest direct hepatitis C with confirmation
Hearing test: US$100–250, CoveredUSA (median ~$150, independent audiologist $100-250, ENT $150-350); HearingAidCostGuide ($150-350 diagnostic)
Body composition analysis: US$40–55, BodySpec ($40-55 per DEXA); BodySpec guide ($40-200 wellness providers; InBody $15-30)
Bone density (DXA): US$150–250, CoveredUSA; primary-md.com
Breast ultrasound (women only): US$331, MDsave Ultrasound Breast Bilateral
CA-125 (women only): US$34, shayahealth.com (reseller), rough
CA 19-9: US$43, shayahealth.com (reseller), rough
Carotid ultrasound: US$250–412, MDsave
Complete blood count: US$29, Quest direct
CEA: US$28, shayahealth.com (reseller), rough
Colonoscopy: US$2,200–3,300, MDsave
Coronary artery calcium score: US$100–150, MDsave; GoodRx; Healthline/AHA
Coronary CT angiography: US$250–400, MDsave; Sidecar Health; bettercare.com
Creatinine and 9 related tests, priced as one panel: US$49, Quest direct comprehensive metabolic panel
Direct bilirubin: US$29–39, Walk-In Lab direct bilirubin $29; total + direct $39 (plus $6 physician fee); not sold standalone by Quest or Labcorp, rough
ENT examination: US$223–401, MDsave ENT new patient office visit (MDsave national average $223)
Female hormone panel (FSH, LH, E2) (women only): US$139–187, Labcorp OnDemand menopause test (FSH, LH, estradiol) $139; Labcorp singles $59+$49+$79=$187; Quest basic women's hormone panel (7 hormones) $225
Free T4: US$89, Labcorp OnDemand TSH + free T4 panel $89 list (checked 2026-10-11); Walk-In Lab free T3 + free T4 panel $69 (reseller, not re-checked)
Gastroscopy (upper GI endoscopy): US$2,000–3,000, MDsave
Gamma-GT: US$29–59, Labcorp OnDemand GGT $59; Walk-In Lab $29 (reseller, plus $6 physician fee)
Hemoglobin A1c: US$39, Quest direct
Hepatitis B surface antigen and 1 related test, priced as one panel: US$99, Quest direct hepatitis B with confirmation
HPV DNA test (women only): US$99–179, Quest high-risk HPV self-swab $99; Labcorp OnDemand HPV cervical screening $179
High-sensitivity CRP: US$65–69, Quest hs-CRP list $65 ($58.50 promo); Labcorp OnDemand list $69 ($51.75 promo); Walk-In Lab $45 reseller
Fasting insulin: US$34–99, Walk-In Lab fasting insulin $34; Quest Insulin Resistance Test Panel (insulin + C-peptide) $99, rough
Low-dose chest CT: US$99–250, Memorial Healthcare System ($99); AARP (up to $250)
Lipase: US$35–39, Labcorp OnDemand $39; Walk-In Lab $35 reseller
Liver elastography (FibroScan): US$241–300, MDsave Fibroscan listing (Saline Memorial); Pueblo Radiology $300
Brain MR angiography: US$616, MDsave MR Angiogram without contrast (head or neck)
Abdominal MRI / MRCP: US$612, MDsave MRI without contrast (any one body part incl. abdomen)
Brain MRI: US$400–800, MDsave (without contrast); iviescan LA market
Breast MRI (women only): US$779, MDsave MRI Breast(s) with and/or without contrast
Pelvic MRI: US$612, MDsave MRI without contrast (any one body part incl. pelvis)
Whole spine MRI: US$1,224, MDsave MRI without contrast x2 (two spine regions), rough
Nasopharyngoscopy: US$634, MDsave Nasopharyngoscopy
Pelvic (gynecologic) ultrasound (women only): US$220, MDsave Ultrasound (one body area, pelvic complete listed)
Physician physical examination and 1 related test, priced as one panel: US$250–400, CVS ($99-150); CoveredUSA median ~$250; Sidecar ($353-502)
PSA (men only): US$52–62, Quest direct-to-consumer
Resting ECG: US$102, CarePriceGuide national average
Lung function test: US$191–397, MDsave spirometry provider listings (4 providers seen), rough
Testosterone: US$69, Quest total testosterone $69; Labcorp OnDemand $69 list ($51.75 promo); Walk-In Lab $59 reseller
Thyroid ultrasound: US$220, MDsave Ultrasound (one body area, thyroid listed)
Total cholesterol and 4 related tests, priced as one panel: US$59, Quest direct lipid panel
TSH: US$49, Quest direct
Uric acid: US$42–49, Quest $42 (gout uric acid test); Labcorp OnDemand $49; Walk-In Lab $29 reseller
Urinalysis: US$40–49, Quest $40; Labcorp OnDemand $49; Walk-In Lab $29 reseller
General eye exam: US$100–150, Warby Parker ($85); America's Best ($80); CoveredUSA median ~$150; VisionTestCost 1280-store median $95
Vitamin D (25-OH): US$75–99, Quest $75; Labcorp OnDemand $99; Walk-In Lab $59 reseller

Radiation from this package's imaging

About 8.3 mSv from the tests we could identify, a typical adult dose for these exams: roughly 2.8 years of natural background radiation (about 3 mSv a year, US average).

This package also lists 9 items we have not matched to a test; if any of them is an X-ray, CT or PET scan, the total is higher.

Bone density (DXA) · about less than 0.01 mSv
Coronary artery calcium score · about 1.7 mSv
Coronary CT angiography · about 5.1 mSv
Low-dose chest CT · about 1.5 mSv

Typical doses from published references (RadiologyInfo.org ↗, Mettler et al. 2008 ↗); the actual dose depends on the scanner and protocol. Ask the center for its own figure.

What US screening guidelines say

The US Preventive Services Task Force is an independent US panel whose recommendations cover people without symptoms. Shown for comparison; it is not advice for you.

What US screening guidelines say about 28 of these tests

Hepatitis C antibody

Recommended (grade A/B)The USPSTF recommends screening all adults aged 18 to 79 years for hepatitis C virus infection. (2020) · USPSTF ↗

Hearing test

Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for hearing loss in adults 50 years or older. (2021) · USPSTF ↗

Bone density (DXA)

Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in postmenopausal women younger than 65 years who are at increased risk, based on a clinical risk-assessment tool. (2025) · USPSTF ↗

Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for osteoporosis in men. (2025) · USPSTF ↗

Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in women 65 years or older. (2025) · USPSTF ↗

Breast ultrasound

Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of supplemental screening with breast ultrasound in women found to have dense breasts on an otherwise negative screening mammogram. (2024) · USPSTF ↗ Note: Same I statement covers ultrasound and MRI as supplemental tests; see mri_breast. The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).

CA-125

Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with the CA-125 blood test. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers CA-125 and transvaginal/pelvic ultrasound; see pelvic_ultrasound.

CA 19-9

Recommended against (grade D)The USPSTF recommends against screening for pancreatic cancer in asymptomatic average-risk adults. (2019) · USPSTF ↗ Note: The recommendation states there are currently no accurate, validated biomarkers for early detection of pancreatic cancer and that the USPSTF does not recommend screening the general population by any method; it does not name CA 19-9. The D grade applies to screening this population by any method, not to CA 19-9 as a separately graded test. It does not apply to people at high risk because of an inherited genetic syndrome or familial pancreatic cancer.

Carotid ultrasound

Recommended against (grade D)The USPSTF recommends against screening for asymptomatic carotid artery stenosis in the general adult population. (2021) · USPSTF ↗

Colonoscopy

Recommended (grade A/B)The USPSTF recommends screening for colorectal cancer in adults aged 45 to 49 years, including with colonoscopy every 10 years. (2021) · USPSTF ↗ Note: Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.

Recommended (grade A/B)The USPSTF recommends screening for colorectal cancer in all adults aged 50 to 75 years, including with colonoscopy every 10 years. (2021) · USPSTF ↗ Note: Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.

Selective (grade C)The USPSTF recommends that clinicians selectively offer colorectal cancer screening, including with colonoscopy every 10 years, to adults aged 76 to 85 years based on overall health, prior screening history and the patient's preferences. (2021) · USPSTF ↗ Note: Grade C reflects an individual decision rather than a blanket recommendation for or against. Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.

Coronary artery calcium score

Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of adding a coronary artery calcium score to traditional risk assessment for cardiovascular disease in asymptomatic adults. (2018; an update is in progress) · USPSTF ↗ Note: Same recommendation covers ABI, high-sensitivity CRP and coronary artery calcium score together; see the other two test rows. The USPSTF has an update in progress specifically on coronary artery calcium scoring for enhanced cardiovascular risk assessment; the 2018 I statement remains the current final recommendation as of 2026-09-25.

Fasting glucose

Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a fasting plasma glucose test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.

Free T4

Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.

Hemoglobin A1c

Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a hemoglobin A1c test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.

Hepatitis B surface antigen

Recommended (grade A/B)The USPSTF recommends screening for hepatitis B virus infection, with an HBsAg test followed by confirmatory testing, in adolescents and adults at increased risk for infection. (2020) · USPSTF ↗ Note: Risk groups include people born in a country with HBV prevalence of 2% or more, US-born people not vaccinated as infants whose parents were born in regions with very high HBV prevalence (8% or more), people with HIV, people who inject drugs, men who have sex with men, and household or sexual contacts of someone with HBV. The recommendation names regions by prevalence, not countries.

HDL cholesterol

Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.

Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.

Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.

HPV DNA test

Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women younger than 21 years. (2018; an update is in progress) · USPSTF ↗ Note: The D statements are against cervical cancer screening in these groups by any test, including HPV testing; see the matching pap_smear rows.

Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (CIN 2 or 3) or cervical cancer. (2018; an update is in progress) · USPSTF ↗ Note: The D statements are against cervical cancer screening in these groups by any test, including HPV testing; see the matching pap_smear rows.

Recommended (grade A/B)The USPSTF recommends screening for cervical cancer in women aged 30 to 65 years with high-risk HPV testing every 5 years, alone or combined with cytology, as an alternative to cytology alone. (2018; an update is in progress) · USPSTF ↗ Note: For women aged 21 to 29 the 2018 statement recommends cytology alone every 3 years, not HPV testing. A draft update posted December 10, 2024 proposes primary HPV testing every 5 years (clinician- or patient-collected) for ages 30 to 65, with cytology every 3 years or cotesting every 5 years as alternatives; not yet a final USPSTF recommendation as of 2026-09-25.

Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women older than 65 years who have had adequate prior negative screening and are not otherwise at high risk. (2018; an update is in progress) · USPSTF ↗ Note: The D statements are against cervical cancer screening in these groups by any test, including HPV testing; see the matching pap_smear rows.

High-sensitivity CRP

Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of adding high-sensitivity CRP to traditional risk assessment for cardiovascular disease in asymptomatic adults. (2018) · USPSTF ↗ Note: Same recommendation covers ABI, high-sensitivity CRP and coronary artery calcium score together; see the other two test rows. The USPSTF lists an update in progress for this statement, but the key questions in its research plan cover coronary artery calcium scoring only, not hs-CRP.

Low-dose chest CT

Recommended (grade A/B)The USPSTF recommends annual screening for lung cancer with low-dose CT in adults aged 50 to 80 years with a 20 pack-year smoking history who currently smoke or quit within the past 15 years. (2021) · USPSTF ↗ Note: Screening should stop once the person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability to have curative lung surgery.

Abdominal MRI / MRCP

Recommended against (grade D)The USPSTF recommends against screening for pancreatic cancer in asymptomatic average-risk adults. (2019) · USPSTF ↗ Note: The USPSTF does not recommend screening the general population for pancreatic cancer by any method; it mentions MRI only as one of the imaging methods studied in people at high risk. The D grade covers the pancreatic-cancer part of an abdominal MRI only, not the liver or bile duct parts of the scan. It does not apply to people at high risk because of an inherited genetic syndrome or familial pancreatic cancer.

Breast MRI

Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of supplemental screening with breast MRI in women found to have dense breasts on an otherwise negative screening mammogram. (2024) · USPSTF ↗ Note: Same I statement covers MRI and ultrasound as supplemental tests; see breast_ultrasound. The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion) and does not address MRI screening for those groups.

Pelvic (gynecologic) ultrasound

Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with transvaginal ultrasound. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers pelvic/transvaginal ultrasound and the CA-125 blood test; see ca125. This csv does not map pelvic_ultrasound to any recommendation about non-ovarian pelvic findings (fibroids, cysts), which the USPSTF does not address.

PSA

Selective (grade C)The USPSTF says the decision to undergo periodic PSA-based screening for prostate cancer should be an individual one for men aged 55 to 69 years. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.

Recommended against (grade D)The USPSTF recommends against PSA-based screening for prostate cancer in men 70 years or older. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.

Resting ECG

Recommended against (grade D)The USPSTF recommends against screening with resting or exercise ECG to prevent cardiovascular disease events in asymptomatic adults at low risk of CVD events. (2018) · USPSTF ↗

Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening with resting or exercise ECG to prevent cardiovascular disease events in adults at intermediate or high risk of CVD events. (2018) · USPSTF ↗

Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for atrial fibrillation with ECG in adults 50 years or older. (2022) · USPSTF ↗

Lung function test

Recommended against (grade D)The USPSTF recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults. (2022) · USPSTF ↗

Thyroid ultrasound

Recommended against (grade D)The USPSTF recommends against screening for thyroid cancer in asymptomatic adults. (2017) · USPSTF ↗

Total cholesterol

TSH

Urinalysis

Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for bladder cancer in asymptomatic adults. (2011) · USPSTF ↗ Note: The USPSTF lists urine dipstick or microscopic urinalysis for hematuria (blood in the urine) among the bladder cancer screening tests it considered. This note covers only that use of a urinalysis.

Vitamin D (25-OH)

Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for vitamin D deficiency in asymptomatic adults. (2021) · USPSTF ↗

General preparation notes for 23 tests in this package

This is general information about how the exam is usually done, not medical advice for you or your family member. Requirements vary by center and by individual health history — always follow the center's own instructions and your own doctor's guidance, especially for any medicine change.

Body composition analysis

Mention when booking: Mention a pacemaker or implanted defibrillator: the test passes a weak electric current through the body and has traditionally not been recommended with these devices.

Total cholesterol

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested, so the test is often done in the morning.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Triglycerides

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Fasting glucose

Usually needs at least 8 hours without food or drink except water beforehand.

Mention when booking: If you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting, and mention it to the center.

Fasting insulin

Usually needs 8 to 12 hours of fasting (no food or drink except plain water) beforehand.

Mention when booking: Mention biotin (vitamin B7) supplements, usually paused for at least a day before this test, and any diabetes medicine; ask the prescribing doctor before changing any medicine.

Urinalysis

Usually needs a clean-catch (midstream) sample; some tests instead ask you to collect all urine passed over 24 hours.

Mention when booking: Ask which specific urine test your provider ordered, since collection instructions vary by test.

Lung function test

Usually asks for no smoking for 24 hours, no heavy meals for at least 2 hours, and no alcohol for at least 4 hours beforehand; wear loose clothing.

Mention when booking: Mention a recent heart attack, stroke or surgery, a chest infection, heart problems or uncontrolled blood pressure; ask whether to bring or hold your usual inhaler.

Abdominal ultrasound

Usually needs about 6 hours without food beforehand; clear fluids other than milk or fizzy drinks are commonly still allowed. Loose, comfortable clothing is easiest.

Mention when booking: Mention if you have type 1 diabetes, so the center can offer an early appointment time.

Pelvic (gynecologic) ultrasound

For a transabdominal scan, drinking water beforehand to fill the bladder is common; for a transvaginal scan, an empty bladder is usual instead.

Mention when booking: Tell the center which type of scan you expect, and mention if you are, or might be, pregnant.

Coronary CT angiography

Usually needs 3 to 4 hours without food and no caffeine beforehand, since caffeine makes it harder to slow the heart for clear pictures; water is often still allowed. Erectile-dysfunction medicines are avoided.

Mention when booking: Mention recent erectile-dysfunction medicine (nitroglycerin is often given), asthma, kidney disease, contrast allergy, metformin or pregnancy; ask the prescribing doctor before changing any medicine.

Coronary artery calcium score

Usually needs about 4 hours without food, caffeine or smoking beforehand; no contrast injection is used for this scan.

Mention when booking: Tell the center if pregnancy is possible.

Afterwards: No recovery time is needed; normal activities can usually resume right away.

Low-dose chest CT

Usually needs no fasting and no contrast injection; loose clothing with no metal is easiest.

Mention when booking: Tell the center if you are, or might be, pregnant.

Abdominal MRI / MRCP

Guidelines on eating vary by center; some ask for a short fast before an abdominal MRI or MRCP. Expect to hold your breath at times during the scan.

Mention when booking: Mention a pacemaker or other implanted device, metal fragments, pregnancy, kidney disease, or claustrophobia.